Recently, we have updated (corrections and revisions) a portion of the landing page regarding “FLD HbA1c,” which we provide as part of our Advanced Remote Health Support Service for members.
The official presentation date for our summer conference (national convention) on “FLD HbA1c” has been confirmed and included in the conference brochure. Following the conclusion of the conference presentation, we plan to commence full-scale marketing and public relations activities. Furthermore, we will provide you with a report on the details, to the extent possible, after …
Read more “Regarding the Presentation of Our Company’s Technology at the Academic Conference”
Currently, our members are utilizing the iOS version of the app for the Advanced Remote Health Support Service. We have received numerous requests for an Android version of the app. Development in this area is already underway, and we anticipate that by autumn or winter, non-members will also be able to use the app on …
Read more “Regarding the Development Aimed at Expanding the Scope of Use for the FLD Application”
The application has been available for use since the middle of this month. We have received feedback from the users, and we would like to share some of their comments verbatim. Please note that these comments are published with the consent of the individuals. Although we publish them without embellishment, we do not include personal …
We are pleased to inform you that for members of the Advanced Remote Health Support Service, we provide the iOS application “FLD HbA1c.” You can view the detailed page for the application at the link below.
We are pleased to announce the launch of the “Advanced Remote Health Support Service” in collaboration with numerous experienced physicians, including those currently practicing. This service offers our cutting-edge, non-contact, non-invasive biomarker analysis application. Depending on your membership category, you may experience simultaneous multi-parameter measurements, including HbA1c, pulse rate, and oxygen saturation. For more details, …
Our company has been advancing the compatibility of the FLD series, which allows non-contact and non-invasive measurement of various indicators (biomarkers) including HbA1c, with a variety of devices. We have now successfully developed a smartphone application capable of simultaneously measuring multiple parameters such as HbA1c, oxygen saturation, and pulse rate. We are currently considering the …
Read more “Regarding the Successful Development of the FLD App for Smartphones”
The collaborative clinical research initiated in the latter half of last year with prestigious universities and university hospitals is progressing, and the findings are scheduled to be presented at an academic conference in the latter half of 2025. We plan to provide further updates on this matter in due course.
In Japan’s healthcare sector, the shortage of healthcare professionals is becoming increasingly critical due to the progression of the declining birthrate and aging population. To address this issue, the promotion of healthcare digital transformation (DX) utilizing digital technology is deemed urgent. According to the “DX White Paper 2023 (Part 2)” published by the Japan Information …
Our company collaborated in the production of NHK’s documentary program “Family History,” which delves into the family histories of notable individuals and celebrities. Our CEO, Osamu Shoji, was credited in the end roll of the episode titled “Ryoma Takeuchi: The Mystery of His Grandfather’s Birth and the Rules of His Clan,” which aired on November …
Read more “We collaborated in the production of the NHK program “Family History.””